Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Arikian

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Healthcare Executive|August 6, 1993
Getting the most out of pharmacoeconomicsS R Arikian
Journal of the American Academy of Dermatology|June 1, 1994
The annual cost of psoriasisS R Arikian, T R Einarson
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 1, 1995
Rank-order stability analysis (ROSA): testing pharmacoeconomic dataT R Einarson, S R Arikian, J J Doyle
The British Journal of Dermatology|April 1, 1994
Cost-effectiveness analysis for onychomycosis therapy in Canada from a government perspectiveT R Einarson, S R Arikian, N H Shear
Oncology (Williston Park, N.Y.)|November 1, 1995
Economic and quality of life outcomes: the four-step pharmacoeconomic research modelS R Arikian, J Suver, T Einarson, et al.
Oncology (Williston Park, N.Y.)|November 1, 1996
Building a computerized disease management operating systemS R Arikian, G G Mario, J J Doyle
Clinical Therapeutics|April 22, 1999
Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: a meta-analysis of randomized controlled trialsT R Einarson, S R Arikian, J Casciano, et al.
The British Journal of Dermatology|April 1, 1994
A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. The Onychomycosis Study GroupS R Arikian, T R Einarson, G Kobelt-Nguyen, et al.
Pharmacoeconomics|February 7, 1995
Pharmacoeconomic analysis of topical treatments for tinea infectionsN H Shear, T R Einarson, S R Arikian, et al.
Clinical Therapeutics|May 1, 1995
Use of anesthesia selection in controlling surgery costs in an HMO hospitalJ Suver, S R Arikian, J J Doyle, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Healthcare Executive|August 6, 1993
Getting the most out of pharmacoeconomicsS R Arikian
Journal of the American Academy of Dermatology|June 1, 1994
The annual cost of psoriasisS R Arikian, T R Einarson
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 1, 1995
Rank-order stability analysis (ROSA): testing pharmacoeconomic dataT R Einarson, S R Arikian, J J Doyle
The British Journal of Dermatology|April 1, 1994
Cost-effectiveness analysis for onychomycosis therapy in Canada from a government perspectiveT R Einarson, S R Arikian, N H Shear
Oncology (Williston Park, N.Y.)|November 1, 1995
Economic and quality of life outcomes: the four-step pharmacoeconomic research modelS R Arikian, J Suver, T Einarson, et al.
Oncology (Williston Park, N.Y.)|November 1, 1996
Building a computerized disease management operating systemS R Arikian, G G Mario, J J Doyle
Clinical Therapeutics|April 22, 1999
Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: a meta-analysis of randomized controlled trialsT R Einarson, S R Arikian, J Casciano, et al.
The British Journal of Dermatology|April 1, 1994
A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. The Onychomycosis Study GroupS R Arikian, T R Einarson, G Kobelt-Nguyen, et al.
Pharmacoeconomics|February 7, 1995
Pharmacoeconomic analysis of topical treatments for tinea infectionsN H Shear, T R Einarson, S R Arikian, et al.
Clinical Therapeutics|May 1, 1995
Use of anesthesia selection in controlling surgery costs in an HMO hospitalJ Suver, S R Arikian, J J Doyle, et al.
Pageof 2